FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313261023> ?p ?o ?g. }

• W4313261023 endingPage "89" @default.
• W4313261023 startingPage "89" @default.
• W4313261023 abstract "This study reports the first clinical evidence of significantly high secretion of matrine in a multi-component botanical (Antitumor B, ATB) into human saliva from the systemic circulation. This is of high clinical significance as matrine can be used as a monitoring tool during longitudinal clinical studies to overcome the key limitation of poor patient compliance often reported in cancer chemoprevention trials. Both matrine and dictamine were detected in the saliva and plasma samples but only matrine was quantifiable after the oral administration of ATB tablets (2400 mg) in 8 healthy volunteers. A significantly high saliva/plasma ratios for Cmax (6.5 ± 2.0) and AUC0-24 (4.8 ± 2.0) of matrine suggested an active secretion in saliva probably due to entero-salivary recycling as evident from the long half-lives (t1/2 plasma = 10.0 ± 2.8 h, t1/2 saliva = 13.4 ± 6.9 h). The correlation between saliva and plasma levels of matrine was established using a population compartmental pharmacokinetic co-model. Moreover, a species-relevant PBPK model was developed to adequately describe the pharmacokinetic profiles of matrine in mouse, rat, and human. In conclusion, matrine saliva concentrations can be used as an excellent marker compound for mechanistic studies of active secretion of drugs from plasma to saliva as well as monitor the patient's compliance to the treatment regimen in upcoming clinical trials of ATB." @default.
• W4313261023 created "2023-01-06" @default.
• W4313261023 creator A5013704257 @default.
• W4313261023 creator A5029612373 @default.
• W4313261023 creator A5034776433 @default.
• W4313261023 creator A5048025879 @default.
• W4313261023 creator A5061594020 @default.
• W4313261023 creator A5077046779 @default.
• W4313261023 creator A5082379620 @default.
• W4313261023 creator A5082969884 @default.
• W4313261023 creator A5086898588 @default.
• W4313261023 date "2022-12-23" @default.
• W4313261023 modified "2023-09-27" @default.
• W4313261023 title "Pharmacokinetic Basis for Using Saliva Matrine Concentrations as a Clinical Compliance Monitoring in Antitumor B Chemoprevention Trials in Humans" @default.
• W4313261023 cites W133954345 @default.
• W4313261023 cites W1498394002 @default.
• W4313261023 cites W1983508148 @default.
• W4313261023 cites W1985521149 @default.
• W4313261023 cites W1988288467 @default.
• W4313261023 cites W2022928755 @default.
• W4313261023 cites W2037705821 @default.
• W4313261023 cites W2039767431 @default.
• W4313261023 cites W2047149754 @default.
• W4313261023 cites W2107420353 @default.
• W4313261023 cites W2117109097 @default.
• W4313261023 cites W2133396456 @default.
• W4313261023 cites W2162661389 @default.
• W4313261023 cites W2190127445 @default.
• W4313261023 cites W2290466312 @default.
• W4313261023 cites W2362771533 @default.
• W4313261023 cites W2395424233 @default.
• W4313261023 cites W2402477428 @default.
• W4313261023 cites W2417420110 @default.
• W4313261023 cites W2535760173 @default.
• W4313261023 cites W2605599884 @default.
• W4313261023 cites W2736871518 @default.
• W4313261023 cites W2806048670 @default.
• W4313261023 cites W2808170676 @default.
• W4313261023 cites W3018966852 @default.
• W4313261023 cites W3033302845 @default.
• W4313261023 cites W3135800772 @default.
• W4313261023 cites W3159022842 @default.
• W4313261023 cites W3197943617 @default.
• W4313261023 cites W3266514 @default.
• W4313261023 doi "https://doi.org/10.3390/cancers15010089" @default.
• W4313261023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36612086" @default.
• W4313261023 hasPublicationYear "2022" @default.
• W4313261023 type Work @default.
• W4313261023 citedByCount "1" @default.
• W4313261023 countsByYear W43132610232023 @default.
• W4313261023 crossrefType "journal-article" @default.
• W4313261023 hasAuthorship W4313261023A5013704257 @default.
• W4313261023 hasAuthorship W4313261023A5029612373 @default.
• W4313261023 hasAuthorship W4313261023A5034776433 @default.
• W4313261023 hasAuthorship W4313261023A5048025879 @default.
• W4313261023 hasAuthorship W4313261023A5061594020 @default.
• W4313261023 hasAuthorship W4313261023A5077046779 @default.
• W4313261023 hasAuthorship W4313261023A5082379620 @default.
• W4313261023 hasAuthorship W4313261023A5082969884 @default.
• W4313261023 hasAuthorship W4313261023A5086898588 @default.
• W4313261023 hasBestOaLocation W43132610231 @default.
• W4313261023 hasConcept C112705442 @default.
• W4313261023 hasConcept C118552586 @default.
• W4313261023 hasConcept C126322002 @default.
• W4313261023 hasConcept C185592680 @default.
• W4313261023 hasConcept C22979827 @default.
• W4313261023 hasConcept C2776545273 @default.
• W4313261023 hasConcept C2908647359 @default.
• W4313261023 hasConcept C3020134792 @default.
• W4313261023 hasConcept C43617362 @default.
• W4313261023 hasConcept C504460877 @default.
• W4313261023 hasConcept C535046627 @default.
• W4313261023 hasConcept C71924100 @default.
• W4313261023 hasConcept C98274493 @default.
• W4313261023 hasConcept C99454951 @default.
• W4313261023 hasConceptScore W4313261023C112705442 @default.
• W4313261023 hasConceptScore W4313261023C118552586 @default.
• W4313261023 hasConceptScore W4313261023C126322002 @default.
• W4313261023 hasConceptScore W4313261023C185592680 @default.
• W4313261023 hasConceptScore W4313261023C22979827 @default.
• W4313261023 hasConceptScore W4313261023C2776545273 @default.
• W4313261023 hasConceptScore W4313261023C2908647359 @default.
• W4313261023 hasConceptScore W4313261023C3020134792 @default.
• W4313261023 hasConceptScore W4313261023C43617362 @default.
• W4313261023 hasConceptScore W4313261023C504460877 @default.
• W4313261023 hasConceptScore W4313261023C535046627 @default.
• W4313261023 hasConceptScore W4313261023C71924100 @default.
• W4313261023 hasConceptScore W4313261023C98274493 @default.
• W4313261023 hasConceptScore W4313261023C99454951 @default.
• W4313261023 hasIssue "1" @default.
• W4313261023 hasLocation W43132610231 @default.
• W4313261023 hasLocation W43132610232 @default.
• W4313261023 hasLocation W43132610233 @default.
• W4313261023 hasOpenAccess W4313261023 @default.
• W4313261023 hasPrimaryLocation W43132610231 @default.
• W4313261023 hasRelatedWork W2351749092 @default.
• W4313261023 hasRelatedWork W2370929226 @default.
• W4313261023 hasRelatedWork W2371871702 @default.

• next